Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	peptide-glutamate-alpha-N-acetyltransferase activity	NAA11 NAA10	1.96e-05	2	89	2	GO:1990190
GeneOntologyMolecularFunction	peptide-serine-alpha-N-acetyltransferase activity	NAA11 NAA10	5.88e-05	3	89	2	GO:1990189
GeneOntologyMolecularFunction	cyclic-nucleotide phosphodiesterase activity	PDE4A PDE5A CNP	2.32e-04	27	89	3	GO:0004112
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 KIF1B KIF19 DYNC1LI1	2.70e-04	70	89	4	GO:0003777
GeneOntologyMolecularFunction	ATP-dependent activity	DNAH3 CECR2 KIF1B ATP6V0A4 KIF19 DYNC1LI1 CHD2 ATP2B4 NLRP3 VCP	4.02e-04	614	89	10	GO:0140657
GeneOntologyMolecularFunction	peptide alpha-N-acetyltransferase activity	NAA11 NAA10	5.41e-04	8	89	2	GO:0004596
GeneOntologyMolecularFunction	cyclic nucleotide binding	PDE4A PDE5A CNP	6.96e-04	39	89	3	GO:0030551
GeneOntologyBiologicalProcess	cyclic nucleotide catabolic process	PDE4A PDE5A CNP	2.46e-05	14	86	3	GO:0009214
GeneOntologyBiologicalProcess	regulation of T-helper 2 cell differentiation	BCL6 IL4R NLRP3	2.46e-05	14	86	3	GO:0045628
GeneOntologyBiologicalProcess	cyclic nucleotide metabolic process	NPPA PDE4A PDE5A CNP	3.68e-05	45	86	4	GO:0009187
GeneOntologyBiologicalProcess	cell cycle process	NCAPG LLGL2 PBRM1 MAP4 WEE1 RBL2 CECR2 NCAPD2 CKAP5 NAA10 DYNC1LI1 BCL6 CCDC57 ATP2B4 SPAG5 VCP NLRP5	8.06e-05	1441	86	17	GO:0022402
GeneOntologyBiologicalProcess	T-helper 2 cell differentiation	BCL6 IL4R NLRP3	8.82e-05	21	86	3	GO:0045064
GeneOntologyBiologicalProcess	regulation of T-helper cell differentiation	BCL6 IL4R IL23R NLRP3	9.40e-05	57	86	4	GO:0045622
GeneOntologyBiologicalProcess	microtubule-based process	DNAH3 LLGL2 MAP4 WEE1 KIF1B KIF19 CKAP5 DYNC1LI1 DYNC2I1 CCDC57 ATP2B4 SPAG5 VCP NLRP5	1.15e-04	1058	86	14	GO:0007017
GeneOntologyBiologicalProcess	establishment of spindle localization	LLGL2 MAP4 SPAG5 NLRP5	1.31e-04	62	86	4	GO:0051293
GeneOntologyBiologicalProcess	spindle localization	LLGL2 MAP4 SPAG5 NLRP5	1.77e-04	67	86	4	GO:0051653
GeneOntologyBiologicalProcess	mitotic cell cycle process	NCAPG PBRM1 MAP4 WEE1 RBL2 NCAPD2 CKAP5 DYNC1LI1 BCL6 CCDC57 SPAG5 VCP	2.15e-04	854	86	12	GO:1903047
GeneOntologyBiologicalProcess	positive regulation of cell development	PBRM1 TENM4 VCAN PDE5A BCL6 SPEN IL4R IL23R NLRP3 ITPKA	2.35e-04	614	86	10	GO:0010720
GeneOntologyBiologicalProcess	regulation of CD4-positive, alpha-beta T cell differentiation	BCL6 IL4R IL23R NLRP3	2.46e-04	73	86	4	GO:0043370
GeneOntologyBiologicalProcess	cilium disassembly	MAP4 KIF19	2.55e-04	6	86	2	GO:0061523
GeneOntologyBiologicalProcess	positive regulation of T-helper cell differentiation	IL4R IL23R NLRP3	2.89e-04	31	86	3	GO:0045624
GeneOntologyBiologicalProcess	cardiac muscle hypertrophy	NPPA PDE5A AKAP13 ATP2B4 RYR2	3.21e-04	142	86	5	GO:0003300
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	PBRM1 BCL6 IL4R IL23R NLRP3	3.42e-04	144	86	5	GO:0045582
GeneOntologyBiologicalProcess	regulation of the force of heart contraction	PDE5A ATP2B4 RYR2	3.49e-04	33	86	3	GO:0002026
GeneOntologyBiologicalProcess	striated muscle hypertrophy	NPPA PDE5A AKAP13 ATP2B4 RYR2	3.65e-04	146	86	5	GO:0014897
GeneOntologyBiologicalProcess	muscle hypertrophy	NPPA PDE5A AKAP13 ATP2B4 RYR2	3.88e-04	148	86	5	GO:0014896
GeneOntologyBiologicalProcess	non-canonical NF-kappaB signal transduction	ZFP91 BIRC2 NLRP2 NLRP3 VCP	4.13e-04	150	86	5	GO:0038061
GeneOntologyCellularComponent	supramolecular fiber	WHRN DNAH3 PARP4 PNN MAP4 KIF1B KIF19 CKAP5 DYNC1LI1 AKAP13 CMYA5 CCDC57 ATP2B4 CNP RYR2 SPAG5	2.53e-05	1179	87	16	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	WHRN DNAH3 PARP4 PNN MAP4 KIF1B KIF19 CKAP5 DYNC1LI1 AKAP13 CMYA5 CCDC57 ATP2B4 CNP RYR2 SPAG5	2.75e-05	1187	87	16	GO:0099081
GeneOntologyCellularComponent	microtubule associated complex	DNAH3 MAP4 KIF1B KIF19 DYNC1LI1 DYNC2I1	5.74e-05	161	87	6	GO:0005875
GeneOntologyCellularComponent	microtubule	DNAH3 PARP4 MAP4 KIF1B KIF19 CKAP5 DYNC1LI1 CCDC57 CNP SPAG5	7.35e-05	533	87	10	GO:0005874
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	WHRN DNAH3 PARP4 PNN MAP4 KIF1B KIF19 CKAP5 DYNC1LI1 AKAP13 CCDC57 CNP SPAG5	8.47e-05	899	87	13	GO:0099513
GeneOntologyCellularComponent	condensed chromosome, centromeric region	NCAPG PBRM1 NCAPD2 CKAP5 DYNC1LI1 SPAG5	1.56e-04	193	87	6	GO:0000779
GeneOntologyCellularComponent	interphase microtubule organizing center	DYNC2I1 NLRP3	1.70e-04	5	87	2	GO:0031021
GeneOntologyCellularComponent	NatA complex	NAA11 NAA10	1.70e-04	5	87	2	GO:0031415
GeneOntologyCellularComponent	condensed chromosome	NCAPG PBRM1 NCAPD2 CKAP5 DYNC1LI1 RGS12 SPAG5	2.95e-04	307	87	7	GO:0000793
GeneOntologyCellularComponent	microtubule organizing center	WHRN PPP4R3B MAP4 NAA11 CKAP5 DYNC1LI1 CDH23 DYNC2I1 CCDC57 IL4R NLRP3 SPAG5	4.13e-04	919	87	12	GO:0005815
GeneOntologyCellularComponent	condensin complex	NCAPG NCAPD2	4.72e-04	8	87	2	GO:0000796
GeneOntologyCellularComponent	paraspeckles	BCL6 NONO	7.54e-04	10	87	2	GO:0042382
GeneOntologyCellularComponent	N-terminal protein acetyltransferase complex	NAA11 NAA10	7.54e-04	10	87	2	GO:0031414
GeneOntologyCellularComponent	chromosome, centromeric region	NCAPG PBRM1 NCAPD2 CKAP5 DYNC1LI1 SPAG5	1.04e-03	276	87	6	GO:0000775
GeneOntologyCellularComponent	cilium	WHRN TBX3 DNAH3 MAP4 VCAN PCDHB15 KIF19 CDH23 DYNC2I1 ATP2B4 SPAG5	1.23e-03	898	87	11	GO:0005929
GeneOntologyCellularComponent	dynein complex	DNAH3 DYNC1LI1 DYNC2I1	1.48e-03	54	87	3	GO:0030286
GeneOntologyCellularComponent	chromosomal region	NCAPG PBRM1 NCAPD2 CKAP5 DYNC1LI1 NLRP2 SPAG5	1.87e-03	421	87	7	GO:0098687
GeneOntologyCellularComponent	Set1C/COMPASS complex	SETD1B BOD1L1	1.98e-03	16	87	2	GO:0048188
GeneOntologyCellularComponent	ATPase complex	PBRM1 CECR2 ATP6V0A4 VCP	2.07e-03	129	87	4	GO:1904949
GeneOntologyCellularComponent	extrinsic component of membrane	TGM3 PDE4A TAMM41 CDH23 RYR2	2.74e-03	230	87	5	GO:0019898
Domain	DAPIN	NLRP2 NLRP3 NLRP5	1.41e-04	22	87	3	PS50824
Domain	PYRIN	NLRP2 NLRP3 NLRP5	1.41e-04	22	87	3	PF02758
Domain	DAPIN	NLRP2 NLRP3 NLRP5	1.41e-04	22	87	3	IPR004020
Domain	PYRIN	NLRP2 NLRP3 NLRP5	1.41e-04	22	87	3	SM01289
Domain	NACHT	NLRP2 NLRP3 NLRP5	1.62e-04	23	87	3	PS50837
Domain	NACHT_NTPase	NLRP2 NLRP3 NLRP5	1.62e-04	23	87	3	IPR007111
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L PARP4 DMXL2 TBC1D9B USF3 PFAS SSH2 MYSM1 MAST3 FARP2	5.59e-07	493	89	10	15368895
Pubmed	Structural, expression, and evolutionary analysis of mouse CIAS1.	NLRP2 NLRP3 NLRP5	5.63e-07	7	89	3	15302403
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L PHKA2 TBX3 PARP4 DMXL2 LLGL2 PFAS AKAP13 COLGALT1 SPAG5 FARP2	8.72e-07	650	89	11	38777146
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WHRN SETD1B TENM4 KIF1B FRMPD1 CKAP5 BOD1L1 SPEN ULK2	1.05e-06	407	89	9	12693553
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	NCOA2 MAP4 BOD1L1 CHD2 SPEN VCP NLRP5	1.13e-06	208	89	7	33230847
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	PHKA2 NCAPG PNN MAP4 NCAPD2 DYNC1LI1 SPAG5	1.20e-06	210	89	7	16565220
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TGM3 NCAPG SETD1B PNN MAP4 NCAPD2 CKAP5 DYNC1LI1 PFAS AKAP13 CHD2 COLGALT1 NONO CNP VCP	1.67e-06	1353	89	15	29467282
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	NCAPG PBRM1 CECR2 NCAPD2 CRYBG1 BOD1L1 CHD2 SPEN ZMYM4	3.34e-06	469	89	9	27634302
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	PNN MAP4 ZFP91 CKAP5 CDH23 AKAP13 SPEN ZMYM4	4.24e-06	361	89	8	26167880
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	PNN WEE1 KIF1B RALGPS2 AKAP13 RGS12 FARP2	4.33e-06	255	89	7	15324660
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	DMXL2 NCAPG PBRM1 MAP4 VCAN DYNC1LI1 BOD1L1 NONO CNP	5.43e-06	498	89	9	36634849
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP2 NLRP3 NLRP5	5.78e-06	14	89	3	20403135
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP2 NLRP3 NLRP5	5.78e-06	14	89	3	12563287
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PPP4R3B PBRM1 PNN MAP4 NCAPD2 NAA10 AKAP13 SPEN NONO	5.88e-06	503	89	9	16964243
Pubmed	Cloning, characterization, and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse.	NAA11 NAA10	6.48e-06	2	89	2	19246321
Pubmed	Identification of a chromosome-targeting domain in the human condensin subunit CNAP1/hCAP-D2/Eg7.	NCAPG NCAPD2	6.48e-06	2	89	2	12138188
Pubmed	Knocking down ETS Proto-oncogene 1 (ETS1) alleviates the pyroptosis of renal tubular epithelial cells in patients with acute kidney injury by regulating the NLR family pyrin domain containing 3 (NLRP3) transcription.	ETS1 NLRP3	6.48e-06	2	89	2	35611792
Pubmed	BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.	BCL6 NLRP3	6.48e-06	2	89	2	38419581
Pubmed	The Q705K and F359L Single-Nucleotide Polymorphisms of NOD-Like Receptor Signaling Pathway: Association with Chronic Pancreatitis, Pancreatic Cancer, and Periodontitis.	NLRP2 NLRP3	6.48e-06	2	89	2	26253076
Pubmed	Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression.	ETS1 POU1F1	6.48e-06	2	89	2	9032233
Pubmed	Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.	NLRP2 NLRP3	6.48e-06	2	89	2	18772453
Pubmed	BCL6 attenuates renal inflammation via negative regulation of NLRP3 transcription.	BCL6 NLRP3	6.48e-06	2	89	2	29072703
Pubmed	Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.	NLRP3 VCP	6.48e-06	2	89	2	27730320
Pubmed	Mutations in NLRP2 and NLRP5 cause female infertility characterised by early embryonic arrest.	NLRP2 NLRP5	6.48e-06	2	89	2	30877238
Pubmed	Centrosome-related genes, genetic variation, and risk of breast cancer.	WEE1 NCAPD2 CKAP5 SPAG5 VCP	6.71e-06	102	89	5	20508983
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TGM3 PBRM1 PNN MAP4 NCAPD2 CKAP5 PFAS CHD2 SPEN VCP	6.82e-06	653	89	10	22586326
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PHKA2 RGPD2 LLGL2 PBRM1 WEE1 CKAP5 NAA10 DYNC1LI1 DYNC2I1 NONO ZMYM4 SPAG5 VCP	7.58e-06	1155	89	13	20360068
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	TRERF1 PBRM1 CECR2 NCAPD2 DYNC1LI1 POU1F1 COLGALT1 SPEN	8.32e-06	396	89	8	26687479
Pubmed	Defining the membrane proteome of NK cells.	PARP4 NCAPG PNN CYP20A1 NCAPD2 CKAP5 NAA10 DYNC1LI1 AKAP13 COLGALT1 NONO ATP2B4 CNP	8.54e-06	1168	89	13	19946888
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	PPP4R3B DNAH3 NCAPG PBRM1 NCAPD2 CKAP5 NAA10 DYNC1LI1 BOD1L1 NONO ATP2B4	1.09e-05	847	89	11	35235311
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	NCAPG PBRM1 PNN NCAPD2 DYNC1LI1 SPEN	1.14e-05	195	89	6	19454010
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 NCAPG PNN MAP4 NCAPD2 BOD1L1 SPEN NONO ZMYM4	1.18e-05	549	89	9	38280479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD MAP4 WEE1 KIF1B RALGPS2 CKAP5 NAA10 AKAP13 BOD1L1 SSH2 RGS12	1.27e-05	861	89	11	36931259
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	PARP4 MAP4 NCAPD2 CKAP5 CRYBG1 AKAP13	1.39e-05	202	89	6	33005030
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TGM3 NCAPG PBRM1 PNN MAP4 NCAPD2 CKAP5 DYNC1LI1 PFAS BOD1L1 COLGALT1 CMYA5 SPEN NONO	1.52e-05	1425	89	14	30948266
Pubmed	Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway.	NAA11 NAA10	1.94e-05	3	89	2	34355692
Pubmed	CMYA5 establishes cardiac dyad architecture and positioning.	CMYA5 RYR2	1.94e-05	3	89	2	35449169
Pubmed	Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinoma.	NLRP2 NLRP3	1.94e-05	3	89	2	37273114
Pubmed	Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.	NPPA PDE5A	1.94e-05	3	89	2	22829024
Pubmed	Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.	PDE4A PDE5A	1.94e-05	3	89	2	10393044
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 PPP4R3B SETD1B WEE1 KIF1B PFAS SPEN NONO ZMYM4	2.03e-05	588	89	9	38580884
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NCOA2 MAP4 VCAN FRMPD1 RALGPS2 ETS1 CRYBG1 BOD1L1 CHD2 COLGALT1 ULK2 SPAG5	2.06e-05	1084	89	12	11544199
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	NCAPG PBRM1 MAP4 NCAPD2 CKAP5 BOD1L1 NONO	2.39e-05	332	89	7	32786267
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 NCOA2 PPP4R3B MAP4 ZFP91 CKAP5 ETS1 NAA10 DYNC1LI1 SPEN NONO ZMYM4	2.45e-05	1103	89	12	34189442
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 PNN MAP4 WEE1 KIF1B ZFP91 CKAP5 DYNC1LI1 SPEN ZMYM4	2.94e-05	774	89	10	15302935
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 JCAD PARP4 MXRA5 PBRM1 WEE1 CHD2 SPEN RYR2	3.83e-05	638	89	9	31182584
Pubmed	CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity.	KIF1B SPAG5	3.87e-05	4	89	2	20852589
Pubmed	ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97.	ULK2 VCP	3.87e-05	4	89	2	30979586
Pubmed	Conditional knockout of TOG results in CNS hypomyelination.	CKAP5 CNP	3.87e-05	4	89	2	28063167
Pubmed	Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population.	VCAN BCL6	3.87e-05	4	89	2	37406588
Pubmed	The major brain isoform of kif1b lacks the putative mitochondria-binding domain.	NPPA KIF1B	3.87e-05	4	89	2	10341097
Pubmed	Interaction of protocadherin-15 with the scaffold protein whirlin supports its anchoring of hair-bundle lateral links in cochlear hair cells.	WHRN CDH23	3.87e-05	4	89	2	33009420
Pubmed	Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.	ETS1 NONO	3.87e-05	4	89	2	29773901
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	TGM3 PBRM1 PNN NONO ZMYM4 VCP	4.01e-05	244	89	6	29884807
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PARP4 DMXL2 KIF1B CHD2 BCL6 CMYA5 ZMYM4 VCP	4.22e-05	497	89	8	23414517
Pubmed	Phosphorylation of BACH1 switches its function from transcription factor to mitotic chromosome regulator and promotes its interaction with HMMR.	MAP4 NCAPD2 CKAP5 NONO	4.24e-05	75	89	4	29459360
Pubmed	Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.	ZFP91 BIRC2	6.44e-05	5	89	2	34942311
Pubmed	Homeostatic serum IgE is secreted by plasma cells in the thymus and enhances mast cell survival.	BCL6 IL4R	6.44e-05	5	89	2	35301301
Pubmed	Cochlear outer hair cells undergo an apical circumference remodeling constrained by the hair bundle shape.	WHRN CDH23	6.44e-05	5	89	2	20332152
Pubmed	Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells.	NLRP3 NLRP5	6.44e-05	5	89	2	34431717
Pubmed	Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1.	NLRP2 NLRP3	6.44e-05	5	89	2	17046979
Pubmed	A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).	NAA11 NAA10	6.44e-05	5	89	2	19480662
Pubmed	Convallatoxin inhibits IL-1β production by suppressing zinc finger protein 91 (ZFP91)-mediated pro-IL-1β ubiquitination and caspase-8 inflammasome activity.	ZFP91 NLRP3	6.44e-05	5	89	2	34825365
Pubmed	p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor.	NCOA2 NONO	6.44e-05	5	89	2	12810069
Pubmed	Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.	TBX3 RBL2	6.44e-05	5	89	2	22002537
Pubmed	Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.	NAA11 NAA10	6.44e-05	5	89	2	16638120
Pubmed	Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome.	ZFP91 NLRP3	6.44e-05	5	89	2	30182366
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 PHKA2 NCAPG RBL2 FRMPD1 NCAPD2 CKAP5 ETS1 SPEN ZMYM4	6.88e-05	857	89	10	25609649
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	NCOA2 PHKA2 PNN VCP	6.92e-05	85	89	4	16051665
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	TRERF1 TBX3 NCAPD2 BOD1L1 SPEN CNP	8.91e-05	282	89	6	23667531
Pubmed	Chromosome condensation by a human condensin complex in Xenopus egg extracts.	NCAPG NCAPD2	9.65e-05	6	89	2	11136719
Pubmed	Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.	TBX3 NPPA	9.65e-05	6	89	2	20457925
Pubmed	Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability.	RBL2 VCP	9.65e-05	6	89	2	23108140
Pubmed	Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development.	TBX3 NPPA	9.65e-05	6	89	2	23936153
Pubmed	A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses.	NLRP2 NLRP3	9.65e-05	6	89	2	17435760
Pubmed	Ectopic expression of Nkx2.5 suppresses the formation of the sinoatrial node in mice.	TBX3 NPPA	9.65e-05	6	89	2	21640717
Pubmed	The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart.	TBX3 NPPA	9.65e-05	6	89	2	15158141
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	MAP4 RBL2 CKAP5 PFAS VCP	9.99e-05	179	89	5	36261009
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 PPP4R3B JCAD DMXL2 RBL2 KIF1B CKAP5 DYNC2I1 BIRC2 CMYA5 ZMYM4 VCP	1.06e-04	1285	89	12	35914814
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TGM3 DMXL2 LLGL2 SETD1B BIRC2 SSH2 NONO ULK2 ATP2B4	1.07e-04	730	89	9	34857952
Pubmed	PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion.	NLRP2 NLRP3	1.35e-04	7	89	2	15817483
Pubmed	Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2.	TBX3 VCAN	1.35e-04	7	89	2	24623077
Pubmed	Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5.	TBX3 NPPA	1.35e-04	7	89	2	19166829
Pubmed	NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.	NLRP2 NLRP3	1.35e-04	7	89	2	15030775
Pubmed	B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.	BCL6 NLRP3	1.35e-04	7	89	2	31087643
Pubmed	Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field.	TBX3 NPPA	1.35e-04	7	89	2	16556915
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L WHRN WEE1 KIF1B RALGPS2 DYNC1LI1 CDH23 DYNC2I1 PDE5A CNP SPAG5 MAST3	1.37e-04	1321	89	12	27173435
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	PBRM1 PNN SPEN ZMYM4	1.46e-04	103	89	4	32744500
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	TBC1D9B PNN BIRC2 BOD1L1 SPEN FARP2	1.57e-04	313	89	6	38270169
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	SECISBP2L PPP4R3B PARP4 TAMM41 PNN NCAPD2 PFAS CNP	1.66e-04	606	89	8	36538041
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	PHKA2 DNAH3 WEE1 NAA10 NONO VCP	1.68e-04	317	89	6	17620599
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	TGM3 PDE4A USF3 NCAPG MAP4 NCAPD2 DYNC1LI1 CHD2 NONO VCP NLRP5	1.74e-04	1153	89	11	29845934
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 NCOA2 RGPD2 DMXL2 PDE4A PBRM1 CKAP5 SSH2 ATP2B4 CNP	1.78e-04	963	89	10	28671696
Pubmed	Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.	BCL6 IL4R	1.79e-04	8	89	2	20299965
Pubmed	Using Gjd3-CreEGFP mice to examine atrioventricular node morphology and composition.	TBX3 NPPA	1.79e-04	8	89	2	30765799
Pubmed	Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions.	NCAPG NCAPD2	1.79e-04	8	89	2	25474630
Pubmed	Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions.	MAP4 CKAP5	1.79e-04	8	89	2	22298430
Pubmed	Differential contributions of condensin I and condensin II to mitotic chromosome architecture in vertebrate cells.	NCAPG NCAPD2	1.79e-04	8	89	2	14532007
Pubmed	Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade.	IL4R NLRP3	1.79e-04	8	89	2	25825216
Pubmed	Tbx2 and Tbx3 regulate the dynamics of cell proliferation during heart remodeling.	TBX3 NPPA	1.79e-04	8	89	2	17460765
GeneFamily	NLR family	NLRP2 NLRP3 NLRP5	8.37e-05	25	62	3	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP2 NLRP3 NLRP5	8.37e-05	25	62	3	994
GeneFamily	N(alpha)-acetyltransferase subunits\|GCN5 related N-acetyltransferases	NAA11 NAA10	7.47e-04	12	62	2	660
GeneFamily	PDZ domain containing	WHRN FRMPD1 RGS12 MAST3	1.83e-03	152	62	4	1220
GeneFamily	GCN5 related N-acetyltransferases	NAA11 NAA10	3.04e-03	24	62	2	1134
GeneFamily	Phosphodiesterases	PDE4A PDE5A	3.04e-03	24	62	2	681
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP13 CMYA5	4.43e-03	29	62	2	396
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KIF1B RALGPS2 AKAP13 FARP2	5.45e-03	206	62	4	682
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF1B KIF19	1.09e-02	46	62	2	622
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD1 FARP2	1.28e-02	50	62	2	1293
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 MYSM1	1.43e-02	53	62	2	532
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	TRERF1 NCOA2 LLGL2 WEE1 KIF1B AKAP13 ATP2B4 NLRP3	3.85e-07	198	89	8	M6511
Coexpression	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	PHKA2 USF3 RALGPS2 ETS1 COLGALT1 IL4R DISP1	5.33e-06	199	89	7	M9238
Coexpression	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN	NCOA2 PHKA2 LLGL2 NCAPD2 CKAP5 CHD2 MAST3	5.50e-06	200	89	7	M6745
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	TRERF1 TENM4 ETS1 BCL6 CNP RYR2	2.14e-05	165	89	6	M9105
Coexpression	GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	TRERF1 PHKA2 RBL2 NCAPD2 PFAS VCP	3.61e-05	181	89	6	M6857
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TRERF1 PPP4R3B PNN RBL2 ETS1 BIRC2 CRYBG1 AKAP13 BOD1L1 CHD2 SSH2 SPEN NONO ATP2B4 MYSM1 MAST3	3.83e-05	1492	89	16	M40023
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	NCAPG PBRM1 VCAN NCAPD2 CRYBG1 AKAP13 CHD2 NONO	5.43e-05	389	89	8	M6520
Coexpression	GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	PPP4R3B DMXL2 SETD1B BOD1L1 BCL6 NLRP3	5.46e-05	195	89	6	M7310
Coexpression	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP	NCOA2 METTL1 DNAH3 NLRP2 NONO RGS12	5.78e-05	197	89	6	M8159
Coexpression	GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP	DMXL2 SSH2 ULK2 IL4R CNP FARP2	6.29e-05	200	89	6	M6369
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	SECISBP2L SETD1B ZFP91 RALGPS2 ETS1 CRYBG1	6.29e-05	200	89	6	M5069
Coexpression	GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP	TAMM41 FRMPD1 CYP20A1 NCAPD2 CNP SPAG5	6.29e-05	200	89	6	M9437
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	RALGPS2 DYNC1LI1 AKAP13 SSH2 LDAH MYSM1	6.29e-05	200	89	6	M9463
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	NCAPG PBRM1 TENM4 KIF1B DYNC1LI1 BIRC2 BOD1L1 SPEN RGS12 ZMYM4 MYSM1	9.04e-05	807	89	11	M14594
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	TENM4 MAP4 KIF1B CHD2 NONO MYSM1	3.54e-05	150	87	6	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 PPP4R3B DMXL2 USF3 PNN MAP4 CECR2 RALGPS2 DYNC2I1 BIRC2 CHD2 ZMYM4	7.86e-05	780	87	12	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	PBRM1 TENM4 MAP4 KIF1B CHD2 NONO MYSM1	9.43e-05	259	87	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	PBRM1 TENM4 MAP4 KIF1B CHD2 NONO MYSM1	1.43e-04	277	87	7	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1	NCAPG WEE1 CECR2 NCAPD2 RALGPS2 PDE5A CNP SPAG5	1.55e-04	376	87	8	GSM538418_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	TENM4 VCAN RYR2 VCP	1.85e-04	69	87	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	DMXL2 TENM4 NAA11 CHD2 NONO MYSM1 RYR2 NLRP5	1.89e-04	387	87	8	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	NCOA2 USF3 PNN RALGPS2 DYNC2I1 BIRC2 CHD2	1.94e-04	291	87	7	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	NCAPG WEE1 CECR2 NCAPD2 RALGPS2 CKAP5 PDE5A SPAG5	2.74e-04	409	87	8	GSM399452_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NCOA2 USF3 PNN CKAP5 BOD1L1 CHD2 SPAG5	2.90e-04	311	87	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	PHKA2 DMXL2 NCAPG TENM4 NAA11 NONO DISP1 MYSM1 RYR2 NLRP5 FARP2	3.02e-04	770	87	11	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500	DMXL2 NCAPG NAA11 RYR2	3.12e-04	79	87	4	gudmap_developingGonad_P2_ovary_500_k3
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	NCAPG WEE1 CECR2 NCAPD2 PFAS TCEAL8 ATP2B4 SPAG5	3.22e-04	419	87	8	GSM538348_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	DMXL2 NCAPG TENM4 MAP4 NAA11 KIF1B CHD2 NONO MYSM1 RYR2 NLRP5	3.30e-04	778	87	11	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	NCAPG PNN CECR2 VCAN ZFP91 CKAP5 PFAS AKAP13 DISP1 SPAG5 VCP	3.34e-04	779	87	11	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
ToppCell	facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM3 MAP4 WEE1 CECR2 ETS1 NONO RGS12	1.18e-07	192	89	7	ec1fd2fb6e71f87189d66261909a84e2be63cacb
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TBX3 CECR2 KIF19 SPEN NLRP5	1.15e-06	169	89	6	4e1322cc5e1733e9fb19e08f739a30206f43cea8
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPPA PNN CYP20A1 CKAP5 CMYA5 RYR2	1.46e-06	176	89	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 WEE1 CECR2 RALGPS2 ETS1 CNP	1.56e-06	178	89	6	9b932b677ae05ac6e12cd6ce97789f8c10e4790b
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMXL2 VCAN KIF1B ZFP91 COLGALT1 NLRP3	1.89e-06	184	89	6	d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPG NCAPD2 RALGPS2 CKAP5 CNP SPAG5	1.89e-06	184	89	6	8f40093de5bb978f046d66e8f05f333686a009a4
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPG TENM4 NCAPD2 CKAP5 PDE5A SPAG5	2.14e-06	188	89	6	95d0a796d62ce6d121e2028c378faffc14b35275
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SETD1B ATP6V0A4 FRMPD1 RALGPS2 ULK2	2.45e-06	107	89	5	410b37beffaf637a2a64c9d0ce7baf81f4bc667c
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SETD1B ATP6V0A4 FRMPD1 RALGPS2 ULK2	2.45e-06	107	89	5	5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USF3 PBRM1 KIF1B ZFP91 CKAP5 ZMYM4	2.49e-06	193	89	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	PDE4A PBRM1 ETS1 AKAP13 BOD1L1 IL4R	2.64e-06	195	89	6	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBX3 NCAPG NCAPD2 CKAP5 ETS1 SPAG5	2.64e-06	195	89	6	a838bddeed487154791b69d27a68673783ff63c0
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBX3 NCAPG VCAN NCAPD2 CKAP5 PDE5A	2.81e-06	197	89	6	29b0a5927f80455eef7b793feabef69fba1a3df1
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	TRERF1 DMXL2 NCAPD2 CKAP5 IL4R SPAG5	3.06e-06	200	89	6	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PHKA2 PDE5A CMYA5 DISP1 RIC3	1.16e-05	147	89	5	b2196046656157d7fcf5b5d1cec7bf521b1e5d8e
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PPP4R3B USF3 RBL2 ETS1 IL4R	1.69e-05	159	89	5	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	1.91e-05	163	89	5	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 CECR2 RALGPS2 ETS1 CNP	2.02e-05	165	89	5	22293c6b55f44636440cd737efb786ff5de3373d
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SECISBP2L USF3 RALGPS2 ETS1 IL4R	2.27e-05	169	89	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPG VCAN NCAPD2 CKAP5 SPAG5	2.27e-05	169	89	5	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	2.27e-05	169	89	5	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TGM3 PDE5A BOD1L1 BCL6 ATP2B4	2.40e-05	171	89	5	2b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TGM3 PDE5A BOD1L1 BCL6 ATP2B4	2.40e-05	171	89	5	dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD AKAP13 ATP2B4 DISP1 ITPKA	2.75e-05	176	89	5	a1b9f8f199a028b3fa85de43fe96bc29f387bfd8
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	TBX3 MXRA5 PCDHB15 PDE5A RYR2	2.75e-05	176	89	5	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	TBX3 MXRA5 PCDHB15 PDE5A RYR2	2.75e-05	176	89	5	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WEE1 CECR2 RALGPS2 ETS1 CNP	2.83e-05	177	89	5	a58c93be9767e3fe8fbb6b0db1210d3a33aac662
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WEE1 CECR2 RALGPS2 ETS1 CNP	2.83e-05	177	89	5	3ed383e5c0b15d9d5e75b98cf6d10609f48fc422
ToppCell	Mild-Lymphoid-T-innate_T\|Mild / Condition, Lineage, Cell class and cell subclass	RBL2 ETS1 ATP2B4 IL23R ITPKA	2.99e-05	179	89	5	abc0fbe101a464a2c85755a974a3d5c2b968fe46
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCAPG NCAPD2 CKAP5 SPAG5 ITPKA	2.99e-05	179	89	5	ac987c9425a1b4106d1b8779a2c5461383eae2ae
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	3.07e-05	180	89	5	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMXL2 NCAPG NCAPD2 CKAP5 COLGALT1	3.40e-05	184	89	5	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD ATP2B4 RYR2 MAST3 ITPKA	3.59e-05	186	89	5	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPG CECR2 NCAPD2 CKAP5 SPAG5	3.59e-05	186	89	5	3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCAPG CECR2 NCAPD2 CKAP5 SPAG5	3.59e-05	186	89	5	ec6d0c29e196e374baa96dd3d506f489c959e77e
ToppCell	E12.5-Mesenchymal\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TBX3 TENM4 VCAN PDE5A TCEAL8	3.77e-05	188	89	5	9778dadc2bd7ded3a723e717d1c8cd3160e99c6c
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	DMXL2 VCAN CDH23 SSH2 NLRP3	3.87e-05	189	89	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JCAD TBX3 ETS1 ATP2B4 DISP1	3.87e-05	189	89	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TBX3 NCAPG NCAPD2 CKAP5 SPAG5	3.87e-05	189	89	5	d049f33115610bda4489968759f754730698b9cd
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	3.87e-05	189	89	5	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE4A VCAN CRYBG1 BCL6 NLRP3	3.97e-05	190	89	5	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD PBRM1 MAP4 ETS1 PDE5A	3.97e-05	190	89	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NCAPG NCAPD2 CKAP5 PDE5A SPAG5	4.07e-05	191	89	5	f764cc21fef87ebad765011098f647ae1bdf6158
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPG TENM4 NCAPD2 CKAP5 PDE5A	4.27e-05	193	89	5	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	JCAD TBX3 ETS1 ATP2B4 DISP1	4.27e-05	193	89	5	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CECR2 RALGPS2 CKAP5 ETS1 CNP	4.38e-05	194	89	5	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DMXL2 NCAPG NCAPD2 COLGALT1 SPAG5	4.49e-05	195	89	5	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	COVID-19_Mild-PLT_5\|COVID-19_Mild / Disease Group and Platelet Clusters	TRERF1 VCAN NCAPD2 ETS1 ATP2B4	4.49e-05	195	89	5	bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	TRERF1 CRYBG1 AKAP13 ATP2B4 RYR2	4.49e-05	195	89	5	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	TRERF1 ETS1 CRYBG1 ATP2B4 RYR2	4.60e-05	196	89	5	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	PDE4A PBRM1 AKAP13 BOD1L1 IL4R	4.60e-05	196	89	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.71e-05	197	89	5	2b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem\|COVID-19_Severe / Disease group, lineage and cell class	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.71e-05	197	89	5	f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.71e-05	197	89	5	f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.71e-05	197	89	5	e70e7d97823a762def3970d94a0e897981a6c922
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.71e-05	197	89	5	bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCell	Non-neuronal-Dividing-IPC-IPC-div1-28\|World / Primary Cells by Cluster	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	787688b68ae5d8768c0a24673ae07ab07616764a
ToppCell	Non-neuronal-Dividing-IPC-IPC-div1\|World / Primary Cells by Cluster	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	72823f26ecabcae1b514b7629cfce010c97b929a
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	ca17e8c0f5bc2c41ce28351a7418d934404e563b
ToppCell	COVID-19_Moderate-CD4+_CTL\|World / disease group, cell group and cell class	LLGL2 RBL2 KIF19 ETS1 ATP2B4	4.94e-05	199	89	5	12ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MXRA5 VCAN RALGPS2 DYNC1LI1 IL4R	4.94e-05	199	89	5	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	d8f904f531bfe091b7d8caaa147ea4a03d627995
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MXRA5 VCAN BCL6 IL4R RYR2	4.94e-05	199	89	5	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	4.94e-05	199	89	5	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	WHRN VCAN PDE5A RGS12	5.04e-05	101	89	4	6523c314166dcf66c3ed13c02ca4b886b068e5b8
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	5.06e-05	200	89	5	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem\|COVID-19_Severe / Disease, condition lineage and cell class	LLGL2 RBL2 KIF19 ETS1 ATP2B4	5.06e-05	200	89	5	31859b8db7ea17e48b7b54e92f0d76aeb755e7ca
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	NCAPG WEE1 NCAPD2 CKAP5 SPAG5	5.06e-05	200	89	5	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial\|2m / Sample Type, Dataset, Time_group, and Cell type.	TBX3 MXRA5 VCAN ETS1 PDE5A	5.06e-05	200	89	5	3da9441c0f1e242f0d195de47ecd4c24dfdca232
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	TBX3 MXRA5 VCAN ETS1 PDE5A	5.06e-05	200	89	5	eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	TBX3 PNN VCAN BOD1L1 SPEN	5.06e-05	200	89	5	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PNN VCAN SPEN MYSM1	6.32e-05	107	89	4	c41bc8810df67158f0ae9f6015c965a8ebd96965
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PNN VCAN SPEN MYSM1	6.32e-05	107	89	4	60b272f5c89bea8a2714f870e18b7ac89a4a4bf6
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SECISBP2L KIF19 BIRC2 CNP	7.29e-05	111	89	4	bb59f1909645fd512f0ea806e5593d4a1c6e25d9
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PARP4 TBC1D9B SPEN CCDC57	8.08e-05	114	89	4	670c9802a59b39241abf6f2c12a3d1844c7db5e5
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SECISBP2L KIF19 BIRC2 CNP	8.94e-05	117	89	4	13f068cc4b4a8e9c66bf0e9e5acf9613654bf3f4
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	WHRN NPPA FRMPD1 PDE5A	1.19e-04	126	89	4	3539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCell	Bronchial_Biopsy-Mesenchymal-Fibroblasts\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	TBX3 MXRA5 VCAN VCP	1.30e-04	129	89	4	13cd10ffdd8f1ef7721884e9efd2cf25f170f414
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 CRYBG1 PFAS CMYA5	1.55e-04	135	89	4	7b456fa9a5f5ce58976a8f1fad18c0f96a096930
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Otof_(Layer_2/3)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NAA11 NLRP2 IL23R	1.63e-04	53	89	3	a41f66edf468f824494a922c3addf429a9125b7f
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SECISBP2L KIF19 BIRC2 CNP	1.64e-04	137	89	4	80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	NPPA MXRA5 RYR2 ITPKA	1.74e-04	139	89	4	9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 BIRC2 IL23R SPAG5	1.79e-04	140	89	4	11e441c3435ad8911ab401ca7d4ae1d3e5fa6eac
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 BIRC2 IL23R SPAG5	1.79e-04	140	89	4	94444b92acfad64d811ebb1545dc1dab64473795
ToppCell	367C-Lymphocytic-ILC-ILC-2\|ILC / Donor, Lineage, Cell class and subclass (all cells)	WHRN MAP4 ZMYM4	1.82e-04	55	89	3	7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c
ToppCell	primary_visual_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	WHRN LLGL2 PNN ATP2B4	1.84e-04	141	89	4	605d7b28e99c943f64b4095855a6f9f70e92cb09
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	JCAD TBX3 CDH23 SPAG5	1.94e-04	143	89	4	ce045ec7c311a1797ae562bec114f9e90604d063
ToppCell	Mild/Remission-B_naive-4\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SECISBP2L USF3 ETS1 IL4R	2.21e-04	148	89	4	dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PHKA2 PDE5A CMYA5 DISP1	2.27e-04	149	89	4	4034805c4eefb8bfb3a357273ccbdb77283ea4a5
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PNN RBL2 SPEN MYSM1	2.51e-04	153	89	4	553dff9688a1996d8f4ba16e60c683593d781389
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PNN RBL2 SPEN MYSM1	2.51e-04	153	89	4	88ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell	droplet-Fat-SCAT-30m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 TENM4 KIF19 SPAG5	2.51e-04	153	89	4	2731c3d4ac40ecc22108f8f3f45a069077159125
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TGM3 DNAH3 KIF19 SAMD15	2.57e-04	154	89	4	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TGM3 DNAH3 KIF19 SAMD15	2.57e-04	154	89	4	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD LLGL2 CMYA5 ATP2B4	2.57e-04	154	89	4	12cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PPP4R3B USF3 ETS1 IL4R	2.63e-04	155	89	4	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD LLGL2 CMYA5 ATP2B4	2.70e-04	156	89	4	fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TGM3 ATP2B4 SPAG5 ITPKA	2.70e-04	156	89	4	2cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 VCAN BCL6 NLRP3	2.77e-04	157	89	4	a98d06cef80bfe8481b0940abce2b29675e45812
Drug	Ginkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	PHKA2 PDE4A TBC1D9B MAP4 WEE1 AKAP13 BCL6 IL4R	1.10e-06	198	89	8	3260_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 PPP4R3B METTL1 TBX3 SETD1B TENM4 CYP20A1	5.70e-06	175	89	7	4072_DN
Drug	cilostamide	NPPA PDE4A PBRM1 RBL2 VCAN PDE5A	7.69e-06	120	89	6	CID000002753
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PPP4R3B TBC1D9B MAP4 AKAP13 IL4R ZNF783 MAST3	1.01e-05	191	89	7	7220_DN
Drug	vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A	PPP4R3B JCAD PHKA2 PDE4A TBC1D9B IL4R MAST3	1.04e-05	192	89	7	7556_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	TENM4 MAP4 PCDHGA1 IL4R RGS12 RYR2 MAST3	1.16e-05	195	89	7	2805_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A	SECISBP2L PHKA2 PDE4A MAP4 IL4R RGS12 FARP2	1.19e-05	196	89	7	3217_DN
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	SECISBP2L WHRN TBX3 FRMPD1 PDE5A ZNF783 MAST3	1.23e-05	197	89	7	4138_UP
Drug	AC1L1IZE	PHKA2 DNAH3 RBL2 DYNC1LI1 ATP2B4 RYR2	1.27e-05	131	89	6	CID000004799
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	TENM4 ULK2 IL4R ZNF783 RYR2 MAST3 FARP2	1.28e-05	198	89	7	5786_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	PHKA2 MAP4 AKAP13 IL4R RGS12 CNP ZNF783	1.32e-05	199	89	7	1509_DN
Drug	Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PHKA2 DMXL2 TENM4 VCAN ATP6V0A4 IL4R RYR2	1.36e-05	200	89	7	2894_UP
Drug	Isoammodendrine	PNN AKAP13	1.51e-05	2	89	2	CID000108191
Drug	rolipram	NPPA PDE4A MAP4 POU1F1 PDE5A AKAP13 IL4R	6.11e-05	253	89	7	CID000005092
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	SECISBP2L WHRN PDE4A MAP4 BCL6 MAST3	7.82e-05	181	89	6	7453_UP
Drug	Dynese	VCAN SPEN	9.02e-05	4	89	2	CID003086011
Drug	Dipyridamole	PDE4A PDE5A	9.02e-05	4	89	2	DB00975
Drug	GSK-3beta Inhibitor VIII; Down 200; 10uM; MCF7; HT_HG-U133A	WHRN PHKA2 CYP20A1 RALGPS2 CCDC57 ULK2	1.08e-04	192	89	6	7092_DN
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A	NCOA2 TBX3 DMXL2 VCAN RALGPS2 BCL6	1.14e-04	194	89	6	4709_UP
Drug	Khellin [82-02-0]; Up 200; 15.4uM; MCF7; HT_HG-U133A	TBX3 RALGPS2 AKAP13 RGS12 ZNF783 MAST3	1.14e-04	194	89	6	4987_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	WHRN PHKA2 DNAH3 MAP4 ULK2 RYR2	1.14e-04	194	89	6	3539_DN
Drug	Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A	NCOA2 PHKA2 MAP4 ULK2 ATP2B4 MAST3	1.14e-04	194	89	6	6076_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	NCOA2 DMXL2 MAP4 RBL2 RGS12 RYR2	1.18e-04	195	89	6	5265_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	NCOA2 PHKA2 MAP4 CYP20A1 RALGPS2 RYR2	1.18e-04	195	89	6	6059_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SECISBP2L DNAH3 MAP4 ATP2B4 IL4R ZNF783	1.21e-04	196	89	6	7226_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A	PDE4A PBRM1 WEE1 PDE5A RGS12 RYR2	1.21e-04	196	89	6	4591_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	PDE4A TBC1D9B MAP4 IL4R RGS12 CNP	1.21e-04	196	89	6	3272_DN
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A	WHRN PBRM1 PCDHGA1 RALGPS2 ATP2B4 FARP2	1.21e-04	196	89	6	2871_UP
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	NCOA2 WHRN TBX3 NPPA VCAN ULK2	1.21e-04	196	89	6	3558_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	WHRN TENM4 MAP4 RALGPS2 RGS12 MAST3	1.21e-04	196	89	6	2762_UP
Drug	Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; HL60; HG-U133A	NPPA MAP4 LDAH IL4R CNP ZNF783	1.21e-04	196	89	6	2023_DN
Drug	Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A	NCOA2 PHKA2 MAP4 ATP2B4 IL4R ZNF783	1.24e-04	197	89	6	1671_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	NCOA2 DNAH3 MAP4 RBL2 ATP2B4 IL4R	1.24e-04	197	89	6	5360_UP
Drug	Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A	TBX3 DMXL2 NAA11 ATP2B4 RGS12 RYR2	1.24e-04	197	89	6	6067_UP
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NCOA2 PPP4R3B MAP4 ULK2 IL4R MAST3	1.24e-04	197	89	6	7213_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A	DNAH3 RBL2 CHD2 BCL6 ULK2 FARP2	1.24e-04	197	89	6	203_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	SECISBP2L MAP4 SPEN IL4R ZNF783 RIC3	1.24e-04	197	89	6	2353_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 TBC1D9B PNN MAP4 CYP20A1 LDAH	1.24e-04	197	89	6	1055_UP
Drug	Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	NCOA2 JCAD WEE1 RBL2 IL4R ITPKA	1.24e-04	197	89	6	4530_DN
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MAP4 CYP20A1 AKAP13 RGS12 RYR2 MAST3	1.28e-04	198	89	6	5545_DN
Drug	Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT_HG-U133A	WHRN ETS1 AKAP13 CCDC57 LDAH RYR2	1.28e-04	198	89	6	5778_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A	WHRN JCAD NPPA VCAN RALGPS2 BCL6	1.28e-04	198	89	6	2285_UP
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; HL60; HG-U133A	DMXL2 SETD1B RBL2 CNP ZNF783 VCP	1.28e-04	198	89	6	1970_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A	PDE4A FRMPD1 CYP20A1 ETS1 ATP2B4 LDAH	1.32e-04	199	89	6	4494_UP
Drug	valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A	TBX3 NPPA DMXL2 VCAN BCL6 ULK2	1.32e-04	199	89	6	6403_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HG-U133A	TGM3 DNAH3 FRMPD1 NLRP2 IL4R MAST3	1.32e-04	199	89	6	315_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	PDE4A MAP4 ULK2 RGS12 ZNF783 FARP2	1.32e-04	199	89	6	6982_UP
Drug	5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA	NCOA2 PPP4R3B TBX3 DNAH3 AKAP13 ULK2	1.35e-04	200	89	6	885_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	WHRN JCAD VCAN BCL6 MAST3 ITPKA	1.35e-04	200	89	6	4542_DN
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A	WHRN JCAD TBC1D9B VCAN AKAP13 MAST3	1.35e-04	200	89	6	5842_DN
Drug	octogen	TRERF1 PBRM1 NLRP3	1.41e-04	26	89	3	CID000017596
Drug	Ro 15-2041	NPPA PDE4A PDE5A	1.41e-04	26	89	3	CID000132434
Drug	bronopol	VCAN FARP2	1.50e-04	5	89	2	CID000002450
Drug	D-22888	PDE4A PDE5A	1.50e-04	5	89	2	CID000197714
Disease	Ogden syndrome (implicated_via_orthology)	NAA11 NAA10	8.59e-06	2	87	2	DOID:0050781 (implicated_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	PPP4R3B TBX3 TENM4 RALGPS2 BCL6 ATP2B4 LDAH RGS12 RYR2 ITPKA	2.83e-05	670	87	10	EFO_0006335, EFO_0006336
Disease	monocyte percentage of leukocytes	TRERF1 CECR2 KIF1B ETS1 CDH23 AKAP13 SSH2 BCL6 ZMYM4 NLRP3	5.88e-05	731	87	10	EFO_0007989
Disease	multiple sclerosis (is_implicated_in)	KIF1B IL4R CNP IL23R	6.57e-05	73	87	4	DOID:2377 (is_implicated_in)
Disease	myocardial infarction (biomarker_via_orthology)	TBX3 NPPA VCAN IL4R NLRP3	1.14e-04	160	87	5	DOID:5844 (biomarker_via_orthology)
Disease	monocyte count	JCAD CECR2 VCAN KIF1B ETS1 CDH23 PDE5A AKAP13 SSH2 BCL6 ATP2B4 DISP1 VCP	1.27e-04	1320	87	13	EFO_0005091
Disease	Hereditary retinal dystrophy	WHRN CDH23	1.79e-04	7	87	2	C0154860
Disease	Malignant neoplasm of breast	TRERF1 NCOA2 TBX3 TBC1D9B LLGL2 PBRM1 PCDHB15 FRMPD1 BIRC2 BOD1L1 SPEN	3.15e-04	1074	87	11	C0006142
Disease	myeloid white cell count	JCAD SETD1B KIF1B ETS1 CDH23 SSH2 COLGALT1 ATP2B4 SAMD15 NLRP3	4.36e-04	937	87	10	EFO_0007988
Disease	Chronic Lymphocytic Leukemia	RBL2 BCL6 FARP2	5.81e-04	55	87	3	C0023434
Disease	neutrophil percentage of granulocytes	TRERF1 ETS1 AKAP13 ITPKA FARP2	5.82e-04	228	87	5	EFO_0007994
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 CDH23	6.56e-04	13	87	2	C1846647
Disease	neutrophil count	TRERF1 JCAD KIF1B ETS1 CDH23 AKAP13 SSH2 SAMD15 ZMYM4 NLRP3 ITPKA FARP2	7.30e-04	1382	87	12	EFO_0004833
Disease	digit length ratio	ETS1 LDAH	1.00e-03	16	87	2	EFO_0004841
Disease	allergic disease	ETS1 BCL6 IL4R ZMYM4 ITPKA	1.01e-03	258	87	5	MONDO_0005271
Disease	psoriasis	NPPA PDE4A ETS1 AKAP13 IL23R	1.30e-03	273	87	5	EFO_0000676
Disease	multiple sclerosis	NCOA2 METTL1 PDE4A KIF1B ETS1 AKAP13 BCL6	1.88e-03	594	87	7	MONDO_0005301
Disease	progranulin measurement	NCOA2 CDH23	1.91e-03	22	87	2	EFO_0004625
Disease	basophil percentage of granulocytes	NCOA2 ETS1 BCL6	1.92e-03	83	87	3	EFO_0007995
Disease	platelet crit	NCOA2 JCAD TGM3 DNAH3 PDE4A ETS1 PDE5A ATP2B4 NLRP3	1.97e-03	952	87	9	EFO_0007985
Disease	Eczema	ETS1 BCL6 IL4R ZMYM4 ITPKA	2.27e-03	310	87	5	HP_0000964
Disease	lymphoma	ZFP91 BCL6	2.27e-03	24	87	2	EFO_0000574
Disease	Prostatic Neoplasms	NCOA2 TBX3 NPPA AKAP13 SPEN LDAH VCP	2.31e-03	616	87	7	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 TBX3 NPPA AKAP13 SPEN LDAH VCP	2.31e-03	616	87	7	C0376358
Disease	pulse pressure measurement	JCAD NPPA MXRA5 PBRM1 TENM4 CYP20A1 RALGPS2 CKAP5 AKAP13 CHD2 LDAH	2.58e-03	1392	87	11	EFO_0005763

Protein segments in the cluster

Peptide	Gene	Start	Entry
HLEEKMPLEDEVVPP	NPPA	46	P01160
TDPVHDLMAEILPEF	VCAN	1361	P13611
MDSIIFPKPEEEHLA	AKAP13	1451	Q12802
KDQPDFISHRMDDVP	DMXL2	1921	Q8TDJ6
DRENPDPHEAELMRK	CDH23	841	Q9H251
IEEHLPKMAEPSSFV	DISP1	1381	Q96F81
SMERPESPKEFLDLD	CECR2	1306	Q9BXF3
FMTHPEFAIEEELPR	ATP2B4	1166	P23634
EDMANLPPHFRERTE	RBL2	136	Q08999
FIHPEETEHEPTKMF	PBRM1	1196	Q86U86
FRKSPEHPVDDIDKM	KIAA0100	2091	Q14667
LPPDITEEEMRKLFE	NONO	81	Q15233
ELAKEIEMASEERPP	MAP4	221	P27816
EPLEVAHDLSKSPDM	LLGL2	791	Q6P1M3
LLPTEMEKTHEDRPF	KIF1B	806	O60333
MEKTHEDRPFPRTVV	KIF1B	811	O60333
PVKSESHLPDRDMDN	JCAD	586	Q9P266
PPVRKFVHEKEIMAE	DYNC1LI1	356	Q9Y6G9
LRKESEMDLPEHKEP	DYNC2I1	41	Q8WVS4
PEELHAMLDVKPDAD	ETS1	426	P14921
ASKELEPEMEFEIEP	PNN	421	Q9H307
PHRPIERADAMDTSD	PDE4A	61	P27815
KEQMPLTPPRFDHDE	PDE5A	131	O76074
VLAKMEEDPDDVPHG	NAA10	56	P41227
PPLDVDEMLERFKTE	NLRP2	116	Q9NX02
KARDDMKRHSPEDPE	NLRP5	141	P59047
PDPKELSAEEIAERM	RIC3	251	Q7Z5B4
RFEEMPETSHLIDLP	PPP4R3B	121	Q5MIZ7
MDLHEKDFSLTEAPP	PARP4	511	Q9UKK3
INDHSPEFPEREMTL	PCDHB15	126	Q9Y5E8
KMLAVDPEAPTEEEH	ITPKA	291	P23677
DPMEDPDDILRAHRS	KIF19	46	Q2TAC6
ADPKEVEEEERHMPK	BOD1L1	2756	Q8NFC6
EPKIRAVSPHFDDMH	CKAP5	1521	Q14008
DPLLARHLEEVEPEM	IL4R	516	P24394
PDKMVPAVREFIAEH	DNAH3	3481	Q8TD57
EEEFEMLHKSIPVDP	CHD2	1226	O14647
TEEEDRDLEAHPMAP	FRMPD1	1351	Q5SYB0
MSPEVEHKEEELILP	CMYA5	551	Q8N3K9
DPMITEIKEIFIPEH	IL23R	431	Q5VWK5
EDVLDPLKMSSPHAE	CCDC57	601	Q2TAC2
FVPGDEPREKMDLVT	CNP	226	P09543
PKETIPEEARSDMHY	BCL6	261	P41182
KDPLEEMVPLSHLEE	MAST3	326	O60307
AMPPIHEDHLEKVFD	CRYBG1	731	Q9Y4K1
PHKFDPDRFDDELVM	CYP20A1	381	Q6UW02
VDEFLPVMFDKHPVS	COLGALT1	521	Q8NBJ5
MDCEEPRHKRVPADE	FARP2	521	O94887
MDETHKESDLEPPEE	SAMD15	126	Q9P1V8
KEPNPEAEELFRMVA	RYR2	3386	Q92736
RNSDVRHAPAEEMPE	PRRT3	71	Q5FWE3
DEEYKNPHTVDRVPM	PHKA2	381	P46019
MADDPEHPDLFLLTD	RALGPS2	526	Q86X27
HPEMVLQSPLDREEE	PCDHGA1	191	Q9Y5H4
SPIKMELLFDPDDEH	NLRP3	201	Q96P20
EEREMRFPTHPKESE	SPAG5	276	Q96R06
FKEDTPVRHLDPEEM	TCEAL8	61	Q8IYN2
HLRPLKTMEPEEEVE	TBX3	86	O15119
DDIHFEPVVQMPEKV	RGPD2	1026	P0DJD1
PIDMDSPEIRELEKF	POU1F1	121	P28069
EEVPLTPEHRMLVEK	FAM178B	236	Q8IXR5
EPTEMHLDFIDDLPQ	SECISBP2L	601	Q93073
GPEKPHDSLDSRIEM	SETD1B	491	Q9UPS6
FVMVEVHRPDSEPDV	WHRN	721	Q9P202
MSLDPEEEAEHPIKI	TGM3	541	Q08188
EEIERDLHRSMPEHP	TBC1D9B	551	Q66K14
EPKDDAMSEHRRHFP	BIRC2	231	Q13490
DPELGVEEEPFHTIM	NCAPD2	1176	Q15021
DHEVPEPESEMKMRL	NCAPG	976	Q9BPX3
RMLVKPLPDSEEEGH	NCOA2	201	Q15596
EFTELLKVMIHPDPE	WEE1	541	P30291
ADDVLRAPHPDMFKE	RGS12	791	O14924
MGDHENRSPVKEPVE	SPEN	1911	Q96T58
VLAKMEEEPDDVPHG	NAA11	56	Q9BSU3
EAPPEHSFVLKEPEM	SSH2	916	Q76I76
DPVPEIRRDHFEEAM	VCP	726	P55072
DHISKEAPEPGMEVV	PFAS	436	O15067
DMEADTVLSPEHPVR	TENM4	116	Q6N022
MDHPDFSSENPKIVD	USF3	1026	Q68DE3
PPMVVEVHDRDRKSE	nan	51	Q6ZUG5
HIMDPPGKNRDVEET	TAMM41	261	Q96BW9
PELPEETLMEREHTD	ULK2	811	Q8IYT8
FSEMDAPLEDPVTKE	ATP6V0A4	201	Q9HBG4
EMLISEEEIPFKDDP	ZFP91	216	Q96JP5
EMAEAPASVRDDPRH	ZSCAN5C	146	A6NGD5
ADHTLRYPVKPEEMD	METTL1	31	Q9UBP6
EKLPTHPFEADLLEM	ZMYM4	1036	Q5VZL5
MAEAAPARDPETDKH	ZNF783	1	Q6ZMS7
SDDEMPVLEIPRKHQ	TRERF1	621	Q96PN7
MDSELKEEIPVHEEF	LDAH	1	Q9H6V9
LEPMEKPIFHDPISE	MXRA5	2536	Q9NR99
QMVEESHEEEELKPP	MYSM1	361	Q5VVJ2